PBXIP1
(Pre-B-Cell Leukemia Homeobox Interacting Protein 1 (PBXIP1))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-PBXIP1 antibody (Catalog #: ARP32948_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Purification
Purified
Indications d'application
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
PBXIP1
(Pre-B-Cell Leukemia Homeobox Interacting Protein 1 (PBXIP1))
Synonymes
im:7138234 Peptide, wu:fb12b01 Peptide, zgc:158151 Peptide, 4732463H20Rik Peptide, HPIP Peptide, pre-B-cell leukemia homeobox interacting protein 1b Peptide, PBX homeobox interacting protein 1 Peptide, pre B cell leukemia transcription factor interacting protein 1 Peptide, pbxip1b Peptide, PBXIP1 Peptide, Pbxip1 Peptide
Sujet
PBXIP1 is the regulator of pre-B-cell leukemia transcription factors (BPXs) function. It inhibits the binding of PBX1-HOX complex to DNA and blocks the transcriptional activity of E2A-PBX1. PBXIP1 tethers estrogen receptor-alpha (ESR1) to microtubules and allows them to influence estrogen receptors-alpha signaling.
Alias Symbols: HPIP
Protein Interaction Partner: CCDC53,CCDC85B,DPPA2,TSNAX,UBQLN4,CCDC53,CCDC85B,DPPA2,TSNAX